Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2025-03-14 00:00:00 ET · period of report 2025-03-12 · accession 0001415889-25-008141 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-14 | 2025-03-12 | PTCT | Boulding Mark Elliott | EVP AND CLO | M - OptEx | $33.02 | +15.5K | 106.3K | +17% | +$512.5K |
| DM | 2025-03-14 | 2025-03-12 | PTCT | Boulding Mark Elliott | EVP AND CLO | S - Sale+OE | $53.30 | -15.5K | 103.9K | -13% | -$827.2K |
| DM | 2025-03-14 | 2025-03-12 | PTCT | Boulding Mark Elliott | EVP AND CLO | M - OptEx | $0.00 | -15.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-12 | M | A | 13,126 | $33.02 | 117,027 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-12 | S | D | 13,126 | $53.31 | 103,901 | D | — | — | (F2) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.00 to 53.71 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2025-03-12 | M | A | 2,395 | $33.02 | 106,296 | D | — | — | |
| 4 | Common | Common Stock | 2025-03-12 | S | D | 2,395 | $53.23 | 103,901 | D | — | — | (F3) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $53.00 to 53.68 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-03-12 | M | D | 13,126 | $0.00 | 0 | D | $33.02 · — to 2029-01-21 | 13,126 Common Stock | (F4) Currently exercisable. |
| 6 | Derivative | Stock Option (Right to Buy) | 2025-03-12 | M | D | 2,395 | $0.00 | 0 | D | $33.02 · — to 2029-01-21 | 2,395 Common Stock | (F4) Currently exercisable. |